Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 2:39 PM ISTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 5:12 PM ISTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....